NEW YORK (GenomeWeb) – KeyGene announced today that it has licensed its proprietary sequence-based genotyping (SBG) technology to the University of Wisconsin-Madison.
The technology allows for genome-wide SNP discovery and genotyping in large populations of organisms in a single experiment. Under the terms of the deal, UW-Madison will be able to offer SBG services in all species to its research collaborators and clients worldwide. Additional terms were not disclosed.
The UW Biotechnology Center will "offer services under KeyGene’s SBG patents to its partners and collaborators to advance our understanding of genetic variation in crops, animals, and model species," Joshua Hyman, director of the center's DNA sequencing facility, said in a statement.
KeyGene has licensed the SBG technology to a number of organizations including the University of Minnesota, LGC, Bayer, and Floragenex.